RSS

Category Archives: Business

Collaboration in Health care – John Abele


John Abele talks about the importance of collaboration in healthcare!

John Abele is an American businessman and the co-founder and a director of Boston Scientific, a medical device company.

In 2006, he was ranked #258 by Forbes Magazine‘s list of “The World’s Richest People,” with an estimated net worth of $2.7 billion. In 2005 he was ranked #132 by Forbes Magazine’s list of “The World’s Richest People,” with an estimated net worth of $4 billion.
Advertisements
 
Leave a comment

Posted by on July 5, 2010 in Business

 

Ranbaxy and Cipla jostle in the Indian Markets


India’s largest pharmaceutical company by revenue, Ranbaxy Laboratories Ltd, has launched an initiative to reach out to smaller towns and villages and invest more in research with an eye on becoming the leader in the generic drugs market in the next two years. Ranbaxy chief executive and managing director Atul Sobti says that with the new initiative, the firm expects to reach a minimum 350,000 doctors by 2012, up from the current 200,000.


The company has already hired nearly 1,500 marketing personnel since the strategy, named Viraat, was kicked off in January—taking its workforce to 4,300. Ranbaxy is aiming to overtake Cipla Ltd as the market leader.Two-thirds of the new hires are field personnel, who will spread out into towns and rural areas to push the company’s over-the-counter and prescription drugs. The rest have been hired at managerial levels.


On the other hand, Cipla has tied up with the Manipal Group-promoted Stempeutics Research to market stem cell-based therapies. Cipla will fund Rs 50 crore within the next two years to conduct clinical trials and to further develop two products being worked on by Stempeutics.


Ranbaxy’s current market share is 4.9% against Cipla’s 5.4%, according ORG IMS. In order to overtake Cipla in the market, Ranbaxy is streamlining its medical communication efforts. Separate strategies are being considered for metros and for towns. If they look deeper, they would also realize that it is important to have a comprehensive digital marketing strategy to reach the high-value prescribers in metros and cities. Even within this strategy, content and channels would have to be fine-tuned depending on the particular molecule/ product/therapeutic class being targeted.

Related articles

 
Leave a comment

Posted by on April 28, 2010 in Business

 

Twenty rules of engagement in new age marketing


Recently, Read this interesting synopsis of the changing rules of engagement in the online world. I have edited a few original writs and added a few, but in essence it replicates ideas of Rich Meyer.

Twenty New rules for engaging your customers

1. Traditional mass marketing is dead.

2. Brand marketers no longer control the  message.
3. Your audience is using social media whether you decide to use social or not.
4. Great marketing is not enough to ensure success.
5. Senior manager need to get middle managers more involved in formulating strategy and implementation of tactics.
6. The best marketing plans in the world mean nothing without flawless execution.
7. To get consumers to buy you product forget about features and start thinking about how you product provides solutions to their problems.
8. There is no such thing as free social media programs.
9. Social media programs need to be tied back to business objectives. Executives need to agree on a measurement criteria for social media programs.
10. Keep it simple. If you can’t clearly explain your strategy and message to your employees than you need to start over.
11. The days of free spending consumers maybe over. Today consumers are saving more and spending less. It’s all about needs rather than want.
12. Web analytics should tell you a story of how your consumers are thinking about your site and products.
13. Employers have all the power now and can lowball new hires and increase workloads on current employees. However this will eventually change and lot more people will seek to leave big companies in search of smaller companies where they can provide a lot more input and be satisfied with their work.
15. Lowering prices is not a marketing or brand strategy.
16. Markets consist of human beings, not demographic sectors.
17. Learn to see the world in the eyes of your customer or website visit.
18. Simplicity is the new currency.
19.Don’t favor credentials over passion.
20. Speed has become even more of a competitive advantage in the age of social media.

Rich’s Rules of New Economy

Related articles

 
Leave a comment

Posted by on September 25, 2009 in Business, health, Health 2.0, Web 2.0

 

P&G as models for Public Health and Social Marketers


What Public Health and Social Marketers Can Learn From P&G: “
P&G brands
While many people in social marketing and public health often look to companies such as Apple, Coca-Cola, McDonald’s and Nike as models for successful consumer marketing to aspire to, P&G stands out among the best and most innovative. What is most attractive to me about P&G is that they have 10 different business areas, ranging from baby care to home care, with 43 brands of over a half billion USD each. If you are in the public health business – not just the obesity, physical activity, breast cancer, HIV prevention or tobacco control business – then the way P&G creates and manages a portfolio of brands, not a unitary one, is where you should go to school.
Here are a few nuggets quoted from their annual report – the core strengths to win:
1. No company in the world has invested more in consumer and market research than P&G. We interact with more than five million consumers each year in nearly 60 countries around the world. We conduct over 15,000 research studies every year. We invest more than $350 million a year in consumer understanding. This results in insights that tell us where the innovation opportunities are and how to serve and communicate with consumers.
2. P&G is the innovation leader in our industry. Virtually all the organic sales growth we’ve delivered in the past nine years has come from new brands and new or improved product innovation. We continually strengthen our innovation capability and pipeline by investing two times more, on average, than our major competitors. In addition, we multiply our internal innovation capability with a global network of innovation partners outside
P&G. More than half of all product innovation coming from P&G today includes at least one major component from an external partner.
3. P&G is the brand-building leader of our industry. We’ve built the strongest portfolio of brands in the industry with 23 billion-dollar brands and 20 half-billion-dollar brands. These 43 brands account for 85% of
sales and more than 90% of profit. Twelve of the billion-dollar brands are the #1 global market share leaders of their categories. The majority of the balance are #2.
4. We’ve established industry-leading go-to-market capabilities. P&G is consistently ranked by leading retailers in industry surveys as a preferred supplier and as the industry leader in a wide range of capabilities including clearest company strategy, brands most important to retailers, strong business fundamentals and innovative marketing programs.
5. Over the decades, we have also established significant scale advantages as a total company and in individual categories, countries and retail channels. P&G’s scale advantage is driven as much by knowledge sharing, common systems and processes, and best practices as it is by size and scope.
6. P&G has earned a reputation as one of the world’s best companies for leaders. We work hard at leadership development because, as a build-from-within company, our future success is entirely dependent on the ongoing strength of our talent pipeline.
Put another way:
Public health agencies should invest significant proportions of their resources in 
(1) talking with and understanding their audiences (rather than a few focus groups here and there), 
(2) innovating in public health programs (rather than recreating wheels or sitting still waiting for
evidence bases to develop), 
(3) creating and sustaining strong public health program brands (not their corporate image), 
(4) being the go-to partner for public health retailers or intermediaries (not someone to avoid because of bureaucracy and painful ‘processes’), 
(5) having in place common systems for getting things done across disease and behavioral risk areas 
(6) developing leaders ratherthan rewarding the status quo.
To sum it all up, as the new CEO Bob McDonald phrases it:

I believe it comes down to one simple and remarkably constant
factor: the clarity and constancy of P&G’s Purpose. Since the Company was
founded, we’ve been in the business of providing daily essentials that improve
the quality of people’s lives. We help people care for their babies, pets and
homes. We make everyday chores easier to do. We help people look and feel
better. We’ve stayed true to the inspiring Purpose of touching and improving
people’s lives in meaningful ways.

 
Leave a comment

Posted by on September 16, 2009 in Business, Marketing, Public health

 

Marketing prescription drugs in India- Guidelines


188px-India_(orthographic_projection).svg

The guidelines for pharmaceutical marketing are typically debated all over the world, more so in India. Many issues are not clear and the drug industry interprets the rules the best it can . Cases of unethical promotion of drugs to the health care industry come up with regularity in the western world. Fortunately, no major case has been reported in the Indian media at present. But thats because many such unethical promotional activities havent come to light. There is an urgent need to inform all the concerned parties of the regulatory Dos and Donts of pharmaceutical marketing in India.

Promotion of drugs in India is governed by three major documents. THE DRUGS AND COSMETICS ACT, 1940 is defined as An Act to regulate the import, manufacture, distribution and sale of drugs and cosmetics in India. It has last been amended in 1995 and new amendments are overdue. The Rules 96 and 97 of THE DRUGS AND COSMETICS RULES, 1945 describe the essential information to be provided regarding labeling of drugs. The product monograph should comprise the full prescribing information necessary to enable a physician to use the drug properly. It should include description, actions, indications, dosage precaution, drug interactions, warnings and adverse reactions.

The OPPI code of conduct ( effective since 1st January 2007) sets out the guidelines to be followed for promotion of prescription drugs to the health care industry. It is based on the IFPMA code and incorporates local region ( India) specific guidelines. it sets out certain principles basic to the ethical promotion of pharmaceuticals in the country. Though it is widely followed, it is not legally binding and the final responsibility for implementation lies with the pharmaceutical marketing organizations themselves.

Below is a short presentation document outlining the Major points in marketing pharmacutical products to the health care industry.
http://bit.ly/nHqwE–

 
Leave a comment

Posted by on June 27, 2009 in Business, Guidelines, India, Marketing

 

Glogging in Medical communication


Mobility and the Future of Marketing and Adver...
I have often seen Glogs on other blogs and websites and have been attracted to them, though i usually don’t like the untidy look that most glogs seem to favor. So i tried to make a slightly tidier glog for myself which could be put to creative business use as a tool for digital marketing media. Well done, a Glog can be very attractive and eye catching.Just an experiment, really, but exciting.

———————————————————-—————————————–

Reblog this post [with Zemanta]
 
Leave a comment

Posted by on April 22, 2009 in Business, Marketing

 

-Medical Communication in India


Animation of an MRI brain scan, starting at th...Image via Wikipedia
Since dabbling with Medical communications professionally, i have realized it has been something i have been doing for quite some time, without knowing. Anything i share with others in the form of media, which is related to Medicine and health, would come under the heading of Medical communications. Medical communications would thus include all my work on Slideshare, youtube, Docstoc, Scribd, Authorstream etc.


One easy way to access a lot of my communications would be by clicking on the icons below!!

Anyways, I was doing some research on Medical animation and came across this presentation on history of computer graphics. I should mention here that the only reason i searched Docstoc and not Scribd for my documents is because of the great links posted by Jason Nazar on facebook, regularly. Thanks Jason.

History Of Computer AnimationFree Legal Forms

Related articles

 
Leave a comment

Posted by on February 12, 2009 in Animation, Business